Search clinical trials for: Placebo Part A

Total 65017 results

Durect

Completed

Trial of Extended Release Bupivacaine for Pain Relief After Surgery (PERSIST)

Post Operative Pain

United States
Universitaire Ziekenhuizen KU Leuven

Completed

Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus (AREBAG)

Type 2 Diabetes Mellitus

Belgium
Phoenix Eagle Company

Suspended

Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers

Pressure Ulcer | Venous Ulcer

Australia
Northumbria University

Completed

Plasma-Induced Changes in the Metabolome Following Polyphenol Consumption

Processes, Metabolic

United Kingdom
University of Memphis
Arizona State University

Completed

Tart Cherry Juice and Markers of Inflammation, CVD, and Diabetes

Obesity | Insulin Resistance | Hyperuricemia | CVD
IRCCS San Raffaele

Recruiting

68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours

Gastroenteropancreatic Neuroendocrine Tumor

Italy
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Terminated

Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL

Extranodal NK/T-cell Lymphoma, Nasal Type

China
Novartis Pharmaceuticals

Completed

A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

Hematological Malignancies

Germany, Switzerland, France
Eisai Inc.

Completed

A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study

Alzheimer's Disease

United States
BiomX, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults

Healthy Volunteers

United States
Janssen R&D Ireland

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

Healthy

United States
Imperial College London
Royal Brompton & Harefield NHS Foundation Trust; British Heart Foundation

Recruiting

Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy (Go-DCM)

Cardiovascular Diseases | Dilated Cardiomyopathy

United Kingdom
Assistance Publique - Hôpitaux de Paris
The Paul Bennetot Foundation

Completed

Pilot Study of a Robot-assisted Intervention for the Management of Care-induced Pain in Dementia (PARODOL)

Moderate to Severe Dementia

France
Krankenhaus Barmherzige Schwestern Linz

Terminated

TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients

Solid Tumours | Adjuvant Chemotherapy | Port-A-Cath

Austria
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Donepezil Prevents Urinary Retention After Extensive Total Hysterectomy

Urinary Retention After Procedure

China
Calvary Hospital, Bronx, NY

Completed

Effect of HPIPC for the Treatment of Ischemic Ulcers in Subjects With PAD

PVD | Arterial Ulcers

United States
University of Hertfordshire
Heart UK

Completed

Acute Cardio-metabolic Responses to Montmorency Tart Cherry Supplementation in Metabolic Syndrome Patients

Hypertension | Metabolic Syndrome | Insulin Resistance

United Kingdom
Zhejiang University

Completed

The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia

Hyperlipoproteinemia
Eli Lilly and Company

Withdrawn

Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) (SPIRIT A1)

Spondylitis, Ankylosing

Spain, United States, Hungary, Belgium, France, Mexico, Netherlands, Poland, Russian Federation, Ukraine, United Kingdom, Canada, Argentina, Germany, Czech Republic
Novo Nordisk A/S

Recruiting

A Research Study of a New Medicine (NNC0650-0013) in Healthy Men

Healthy Participants

Germany
Yuji KUMAGAI
Aetas Pharma Co. Ltd.

Completed

First-in-Human Dose Escalation Study of M201-A in Healthy Japanese Subjects

Healthy Volunteers

Japan
Kitasato University
Aetas Pharma Co. Ltd.

Completed

Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects

Healthy Volunteers

Japan
Anthera Pharmaceuticals

Completed

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus (PEARL-SC)

Systemic Lupus Erythematosus

United States, Argentina, Brazil, Chile, Colombia, Hong Kong, India, Mexico, Peru, Philippines, Taiwan
Mansoura University

Completed

Endometrial Scratching Prior to Controlled Ovarian Stimulation (COH) in Women Undergoing In-vitro Fertilization With Previous IVF Failure (ESICOHF)

Infertility

Egypt
University of Exeter

Completed

Effects of Blueberry Juice Consumption on Cognitive Function in Healthy Older People

Cognitive Aging
Military Institute od Medicine National Research...

Completed

Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT

Early Release of Chromogranin A (CgA)
Vanderbilt University
University of Miami; National Institute on Minority Health and Health Disparities... and other collaborators

Completed

Tailoring a Lifestyle Intervention to Address Obesity Disparities Among Men

Obesity | Weight Loss

United States
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Completed

Training Community Members to Deliver HIV Prevention Programs to Urban Youth

HIV Infections | HIV

United States
University Hospital Southampton NHS Foundation...

Not yet recruiting

Atrial Fibrillation Driver Study

Atrial Fibrillation | Fibrosis Myocardial
Verastem, Inc.

Terminated

Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects

Pancreatic Cancer

United States
A-Mansia Biotech S.A.

Completed

Study to Evaluate the Effect of Pasteurized Akkermansia Muciniphila (pAkk) on Complaints Related to IBS

Irritable Bowel Syndrome

Germany
Novo Nordisk A/S

Completed

Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Anthera Pharmaceuticals

Withdrawn

MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP

Idiopathic Thrombocytopenic Purpura | Immune Thrombocytopenic Purpura
The Archer-Daniels-Midland Company
Merieux NutriSciences (China)

Not yet recruiting

Determination of the Safety and Efficacy of Two Probiotic Strains (CODECS)

Gastrointestinal Dysfunction
Alpha Tau Medical LTD.

Recruiting

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

Recurrent Squamous Cell Carcinoma

United States, Israel, Canada
Galderma R&D

Completed

Safety and Efficacy of Nemolizumab in PN

Prurigo Nodularis

Germany, Poland, France, Austria
SciNeuro

Completed

A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease

Neurodegenerative Diseases | Alzheimer's Disease

Australia
Kitasato University
Aetas Pharma Co. Ltd.

Unknown

First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation

Paroxysmal Atrial Fibrillation

Japan
GlaxoSmithKline

Completed

Breast Cancer With Over-expression of erbB2-BRAINSTORM

Cancer

Thailand, Singapore, Philippines
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

Partial Epilepsy

Portugal
Sun Yat-sen University

Unknown

Research for Prevention and Treatment of NSAIDs Related Gastrointestinal Side Effects

Non-steroidal Anti-inflammatory Drug Adverse Reaction

China
OliPass Australia Pty Ltd
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002

Osteoarthritis

Australia
GlaxoSmithKline
Medicines for Malaria Venture

Completed

Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse

Malaria, Vivax

Thailand, India, Brazil, Ethiopia, Peru, Bangladesh, Cambodia, Philippines
The Catholic University of Korea

Completed

Postoperative Pain After Total Laparoscopic Hysterectomy: a Comparison of Single-port and Three-port Laparoscopy

Postoperative Pain | Uterine Disease
Eli Lilly and Company

Completed

A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Non-Small-Cell Lung Carcinoma

United States
Cancer Institute and Hospital, Chinese Academy...

Unknown

Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer

Lung Neoplasm

China
Sun Yat-sen University

Recruiting

Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance With Zanubrutinib for Newly-Diagnosed MCL

Mantle Cell Lymphoma | Newly-diagnosed Mantle Cell Lymphoma

China
PHARMENTERPRISES LLC

Not yet recruiting

Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19

SARS-CoV-2 Infection | Lung Fibrosis
Valneva Austria GmbH

Completed

COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222 (COV-COMPARE)

SARS-CoV-2 Virus Infection

United Kingdom
Loyola University

Completed

Port Size and Post-Operative Pain Perception by Patients

Pain

United States

Search clinical trials for: Placebo Part A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations